Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	28.74	20.11	15.62
Graham Fair Price	21.85	18725.71	15368.14
PEG	-62.84	0.18	-0.50
Price/Book	-11.64	1.34	1.51
Price/Cash Flow	-110.94	-57.19	-27.11
Prices/Earnings	-32.61	7.62	11.31
Price/Sales	11.49	2.07	1.86
Price/FCF	-110.94	-57.19	-27.11
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.73	0.14	0.14
Operating Margin	-8.29	0.09	0.10
ROA	36.59	0.02	0.01
ROE	0.03	0.04	31.11
ROIC	0.05	0.04	-20.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.16	-0.24	-33.88
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.76	-0.23	-70.35
EPS QOQ	-0.23	0.41	81.36
FCF QOQ	-1.52	0.55	-63.56
Revenue QOQ	0.14	-0.16	11.07
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	122.61	152.08	24.04
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.04	0.04	0.44
Quick Ratio	1.26	1.31	3.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17720.68	18857.08	6.41
Cash	7504.01	7320.25	-2.45
Capex	-51.22	-84.95	-65.85
Free Cash Flow	-988.47	-440.63	55.42
Revenue	14425.85	12167.02	-15.66
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.41	1.47	3.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.69	-3.48	-29.23
Naive Interpretation	Member

06 - Financial Health · Weak

Rating